Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024
-
New Guidelines on Use of Statins in HIV Care
Read the new guidelines on use of statins in New Guidelines for Use of Statins by People with HIV to Prevent Cardiovascular Events (HIV.gov blog, 2/29/24).News Article updated on 03/01/2024 -
National Clinician Consultation Center
-
Syphilis Cases Continue to Climb
Syphilis cases continue to climb in the U.S. In April 2023, CDC reported a 32% increase in cases from 2020 to 2021 (133,954 to 176.713 cases). In 2022, cases had jumped yet again, to 203,500.News Article updated on 03/04/2024 -
340B and AIDS Drug Assistance Programs: Getting the Best Price
Information for ADAPS on leveraging discounts and rebates under the 340B program and compliance requirements.Resource updated 05/29/2024
-
Keep Track of CROI 2024: HIV.gov Blogs
CROI 2024 is underway. Keep track via HIV.gov blogs.News Article updated on 03/05/2024 -
Community Engagement Learning Series Part One: Successful Strategies to Recruit Planning Body Members
Review of collaborative integrated prevention and care planning recruitment activities.Resource updated 05/29/2024
-
HepVu Map on Hep C, Opioids
New data on Hepatitis C and other health indicators are available on HepVu.News Article updated on 03/08/2024 -
CROI 2024 Highlights from HIV.gov
CROI 2024 highlights from HIV.gov:News Article updated on 03/07/2024 -
National ADAP Formulary Database
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024
-
National HIV PrEP Curriculum
Online learning portal for clinicians on pre-exposure prophylaxis (PrEP) for prevention of HIV.Resource updated 03/13/2024
-
Work Plan Template for ADAP Emergency Relief Funds
Suggested format for ADAP work plans.
Resource updated 09/19/2023
-
Pharmacy Benefits Manager Toolkit
Planning and implementation steps when using a Pharmacy Benefit Manager (PBM) to administer an AIDS Drug Assistance Program (ADAP).
Resource updated 09/19/2023
-
HRSA HAB Ryan White Grants Administration
Resources for RWHAP recipients on administering their grants, including reverse site visit materials.Resource updated 02/22/2024
-
HRSA HAB Notice of Funding Opportunity (NOFO) Announcements
Pre-application webinars for Notice of Funding Opportunity (NOFO) announcements from HRSA's HIV/AIDS Bureau for the Ryan White HIV/AIDS Program (RWHAP).
Resource updated 03/07/2024
-
HIV.gov: Recursos en español
Enlace principal a recursos clave de sitios del gobierno federal de los EE.UU. en español relacionados con el VIH/SIDA.
Resource updated 09/20/2023
-
HIV.gov
Portal for HIV/AIDS information from the U.S. federal government, including the Ending the HIV Epidemic initiative.
Resource updated 03/28/2024
-
The Evolution of Ryan White HIV Care
Cross-post of a guest editorial by Dr. Laura Cheever, HRSA Associate Administrator for HIV/AIDS, from Leading with Race, NMAC.
Blog updated 01/07/2021
-
Integrated HIV/AIDS Planning Technical Assistance Center
Support for Part A and B recipients and their planning bodies around integrated HIV/AIDS planning efforts. Project period: 2016-2027.
RWHAP Technical Assistance Provider updated on 05/30/2024
-
Orientation Resources for Ryan White Staff
Many RWHAP recipients have some type of new employee orientation, a fundamental requirement for any agency considering the amount of turnover in the HIV workforce.
Blog updated 02/28/2022